Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review.
Background
The outbreak of Coronavirus disease 2019 (COVID-19) has caused more than 180 million infections and 3.9 million deaths. To date, emerging clinical evidence has shown the synergetic benefits of Chinese herbal injections in treating this contagious respiratory disease. This review aims to summarize and analyze the efficacy and safety of Chinese herbal injections in the therapy of COVID-19.


Methods
The literature from 3 electronic databases, PubMed, CNKI, and Web of Science, were searched using the search terms "COVID-19", "SARS-CoV-2", "traditional Chinese medicine", "herb", "herbal", and "injection". Then the identified articles were comprehensively evaluated.


Results
Limited data demonstrated that Chinese herbal injections could significantly improve the clinical outcomes of COVID-19 patients, especially in combination with conventional treatment strategies. The benefits of which were mainly associated with the relief of symptoms, prevention of secondary infection, regulation of inflammation and immune function. There was also evidence showing the inhibitory effects on SARS-CoV-2 replication in vitro. Nevertheless, available real-world data suggested the increased risk of adverse event. Furthermore, the defects of existing researches and the insights for discovering novel antiviral drugs were prospectively discussed.


Conclusion
Evidence-based advances revealed that Chinese herbal injections such as XueBiJing injection and ShenMai injection, exerted potent effects against COVID-19. Further laboratory researches and clinical evaluation are needed to gather scientific evidence on the efficacy and safety.
['Zhu|Xiao-Bin|XB|', 'Guo|Meng|M|', 'Zhang|Zhi-Hui|ZH|', 'Sun|Li-Hua|LH|', 'Liu|Lei|L|', 'Zhou|Li-Juan|LJ|', 'Shan|Chun-Lei|CL|', 'Yang|Yi|Y|', 'Kan|Lian-Di|LD|', 'Li|Liu-Cheng|LC|']
Chinese herbal injection Coronavirus COVID-19 SARS-CoV-2 herb